NasdaqCM - Nasdaq Real Time Price
USD
Intensity Therapeutics, Inc. (INTS)
3.0000
-0.1000
(-3.23%)
At close: November 6 at 4:00:00 PM EST
3.0000
0.0000
(0.00%)
Overnight: 9:05:59 PM EST
This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed.
Loading chart for INTS
- Previous Close
3.1000 - Open
3.0100 - Bid 2.6700 x 200
- Ask 4.4600 x 200
- Day's Range
2.9150 - 3.1900 - 52 Week Range
2.8000 - 15.0000 - Volume
15,416 - Avg. Volume
23,268 - Market Cap (intraday)
9.904M - Beta (5Y Monthly) 3.04
- PE Ratio (TTM)
-- - EPS (TTM)
-3.8900 - Earnings Date (est.) --
- Forward Dividend & Yield -- (0.00%)
- 1y Target Est
18.67 - Zacks Rating Neutral
Recent News
View MorePerformance Overview
Trailing total returns as of 11/6/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
INTS
70.73%
S&P 500 (^GSPC)
7.76%
1-Year Return
INTS
75.26%
S&P 500 (^GSPC)
9.77%
3-Year Return
INTS
96.19%
S&P 500 (^GSPC)
68.96%
5-Year Return
INTS
97.98%
S&P 500 (^GSPC)
57.04%
Earnings Trends
View MoreAnalyst Insights
View MoreStatistics
View MoreValuation Measures
-
Market Cap
-
Enterprise Value
-
Trailing P/E
-
Forward P/E
-
PEG Ratio (current)
-
Price/Sales (ttm)
-
Price/Book (mrq)
-
Enterprise Value/Revenue
-
Enterprise Value/EBITDA
Financial Highlights
Profitability and Income Statement
-
Profit Margin
0.00%
-
Return on Assets (ttm)
-89.91%
-
Return on Equity (ttm)
-195.88%
-
Revenue (ttm)
--
-
Net Income Avi to Common (ttm)
-11.16M
-
Diluted EPS (ttm)
-3.8900
Balance Sheet and Cash Flow
-
Total Cash (mrq)
9.53M
-
Total Debt/Equity (mrq)
1.03%
-
Levered Free Cash Flow (ttm)
-6.28M
